Cancer has recently become a major illness facing almost 40% of the adults’ population in U.S. based on the statistics provided by the National Cancer institute (NCI), over 14.5m citizens in U.S have been diagnosed with cancer. The statistics reveal that this number is to project up to 19 million in the year 2024. The slow growth has been mainly attributed to better projections and advances in medical technology to fight cancer. Companies such as Tempus have played a significant in this progress. Tempus is currently leading the charge in data enabled precision medicine. It is co-founded by Eric Lefkofsky who is also a co-founder of Groupon.
Technological developments such as electronic health records (EHRs) has made medical practice to be perceived to speed up with modern technology. However, that’s not the case as it is with the perception of many individuals. Eric Lefkofsky had not realized how insufficient data collection and advancement in medical technology was until his wife was found with breast cancer. He realised that the main ordeal was not the generation of data. The major concern is how that generated data is used. This was the main reason that drove to the formation of Tempus. The main objective of the formation of the firm was to improve the way cancer care is provided. The firm also had a major concern of overcoming the ways in which important information is gathered and stored for cancer patients. They were able to transform the text fields with pertinent notes into a well-structured data which can be used in advanced treatment of cancer patients.
The significant works of Eric Lefkofsky and Tempus have allowed clinical information about a cancer patient to be combined with molecular information which has been gathered via genome sequence. This is of great importance since human genes contains information for a lot of things which aids in fighting diseases such as cancer. Individuals such as Eric Lefkofsky and other medical geniuses advocating for data enabled precision believe that through advanced technology such as Tempus, cancer patient can receive quality treatment.
Eric Lefkofsky was born in September 1969 in Michigan. The most interesting thing with him is that he is less than 50 years if age.
He is well educated since in 1991 he got his degree in the University of Michigan with high honours.
Eric Lefkofsky info: lefkofskyfoundation.com/